HTAs and access to rare diseases therapies: How can clinicians
assist in the healthcare assessment of treatments for patients with primary
immune deficiencies?
Affiliations: Professor of Clinical Immunology, University of
Oxford, Oxford, UK | Department of Medicine, John Radcliffe Hospital,
Oxford, UK. E-mail: [email protected]